We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 87

Court grants summary judgment in Omnicare v. UnitedHealth Group
  • McDermott Will & Emery
  • USA
  • February 3 2009

The decision in this gun-jumping case emphasizes the importance of antitrust guidance during pre-closing due diligence and agreement negotiation


Pharmacist order challenges Commission’s power of investigation
  • McDermott Will & Emery
  • European Union, France
  • February 6 2009

The French National Pharmacist Order has launched a challenge before the European Court of First Instance against the European Commission's powers of investigation in competition cases


Court grants summary judgment in Omnicare v. UnitedHealth Group
  • McDermott Will & Emery
  • USA
  • February 3 2009

The decision in this gun-jumping case emphasizes the importance of antitrust guidance during pre-closing due diligence and agreement negotiation


The extent of supply limitation on EU pharmaceutical trade
  • McDermott Will & Emery
  • European Union
  • December 16 2008

In its 16 September 2008 judgment, the European Court of Justice (ECJ) gave further guidance on how a dominant pharmaceutical supplier can justify limiting supplies to wholesalers


U.S. Supreme Court hears oral argument in Phoebe Putney hospital merger challenge
  • McDermott Will & Emery
  • USA
  • November 27 2012

In oral argument in FTC v Phoebe Putney Health System, Supreme Court Justices focused on whether the state legislature clearly articulated a state policy to displace competition with regulation, in a case challenging the application of the state action doctrine to a hospital merger to monopoly


Court orders divestiture of consummated physician practice acquisition
  • McDermott Will & Emery
  • USA
  • February 14 2014

In a challenge brought both by private plaintiffs and the government, a court has ruled that a health system’s acquisition of a competing physician


GlaxoSmithKline infringed competition rules by restricting parallel trade
  • McDermott Will & Emery
  • European Union, Greece
  • April 4 2008

Advocate General Ruiz-Jarabo has delivered a non-binding opinion to the European Court of Justice (ECJ), finding that GlaxoSmithKline Plc (GSK) abused its dominant position by limiting distribution of certain pharmaceuticals to Greek wholesalers


Market definition spurs district court’s decision denying product ownership challenge
  • McDermott Will & Emery
  • USA
  • September 22 2010

The Federal District Court in Minnesota recently decided Ovation Pharmaceutical did not violate federal or state antitrust laws when it acquired Indocin IV and NeoProfen, the only two drugs approved for treatment of a specific heart condition that primarily affects premature babies, because the challengers failed to establish that the drugs were in the same product market


When is most favored too favored?
  • McDermott Will & Emery
  • USA
  • October 21 2010

The DOJ and Michigan are challenging Blue Cross Blue Shield of Michigan's most favored nations contracts under federal and Michigan antitrust law


Court certifies class in hospital merger antitrust lawsuit
  • McDermott Will & Emery
  • USA
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action